David Shin
Direttore operativo presso Limelight Bio, Inc.
Profilo
David Shin is currently the Chief Operating Officer at Limelight Bio, Inc. He is also a Venture Partner & CSO at SRI Capital Partners LLC and Sri Capital.
Previously, he held positions as the Director of Technology at Thermo Fisher Scientific, Inc. from 2004 to 2007, Senior Director at Clearview Projects, Inc. in 2008, Vice President at Cascadian Therapeutics LLC from 2014 to 2016, and Vice President at Alpine Biosciences, Inc. in 2014.
He also worked as a Senior Analyst at Ayer Capital Management LP.
Dr. Shin received his undergraduate degree from Carnegie Mellon University in 1993 and his doctorate degree from the University of Pennsylvania in 1997.
Posizioni attive di David Shin
| Società | Posizione | Inizio |
|---|---|---|
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Direttore operativo | 01/09/2017 |
Sri Capital
 Sri Capital Investment ManagersFinance Sri Capital (Sri Capital) is venture capital firm founded in 2007. Sri Capital headquartered in the US. | Investitore di Private Equity | - |
Precedenti posizioni note di David Shin
| Società | Posizione | Fine |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Corporate Officer/Principal | 01/05/2016 |
Alpine Biosciences, Inc.
 Alpine Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alpine Biosciences, Inc. provided research and development of protocells for treatment of rare diseases and cancer. The company was headquartered in Seattle, WA. | Corporate Officer/Principal | 01/08/2014 |
| Clearview Projects, Inc. | Corporate Officer/Principal | 01/03/2008 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 31/12/2006 |
Ayer Capital Management LP
 Ayer Capital Management LP Investment ManagersFinance Founded in 2008 by Jay Venkatesan, Ayer Capital Management LP is a hedge fund manager located in San Francisco. | Analyst-Equity | - |
Formazione di David Shin
| Carnegie Mellon University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| THERMO FISHER SCIENTIFIC | Health Technology |
| Aziende private | 6 |
|---|---|
Ayer Capital Management LP
Ayer Capital Management LP Investment ManagersFinance Founded in 2008 by Jay Venkatesan, Ayer Capital Management LP is a hedge fund manager located in San Francisco. | Finance |
| Clearview Projects, Inc. | |
Limelight Bio, Inc.
Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Alpine Biosciences, Inc.
Alpine Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alpine Biosciences, Inc. provided research and development of protocells for treatment of rare diseases and cancer. The company was headquartered in Seattle, WA. | Commercial Services |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
Sri Capital
Sri Capital Investment ManagersFinance Sri Capital (Sri Capital) is venture capital firm founded in 2007. Sri Capital headquartered in the US. | Finance |
- Borsa valori
- Insiders
- David Shin
